Sartorius Stedim Biotech, Repligen Partner on Perfusion-Enabled Bioreactors

Sartorius Stedim Biotech (SSB) said today it will integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion-enabled bioreactors, through a collaboration whose value was not disclosed.The collaboration plans to create a single control system for 50 L to 2,000 L bioreactors used in perfusion cell culture applications. The single interface is designed to control cell growth, fluid mana